{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:19:20Z","timestamp":1780946360753,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Isfahan Endocrine and Metabolism Research Center.","award":["9531"],"award-info":[{"award-number":["9531"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s43440-021-00220-8","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T09:03:08Z","timestamp":1617786188000},"page":"806-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Alleviating neuropathy of diabetic foot ulcer by co-delivery of venlafaxine and matrix metalloproteinase drug-loaded cellulose nanofiber sheets: production, in vitro characterization and clinical trial"],"prefix":"10.1007","volume":"73","author":[{"given":"Rokhsareh","family":"Meamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Chegini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-5798","authenticated-orcid":false,"given":"Jaleh","family":"Varshosaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Siavosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"issue":"2","key":"220_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"220_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/wound.2015.0635","volume":"4","author":"RG Frykberg","year":"2015","unstructured":"Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015;4(9):560\u201382.","journal-title":"Adv Wound Care"},{"issue":"10","key":"220_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1464-5491.2011.03279.x","volume":"28","author":"PW Moxey","year":"2011","unstructured":"Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, et al. Lower extremity amputations\u2014a review of global variability in incidence. Diabetic Med. 2011;28(10):1144\u201353.","journal-title":"Diabetic Med"},{"issue":"3","key":"220_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/bioengineering5030051","volume":"5","author":"E Gianino","year":"2018","unstructured":"Gianino E, Miller C, Gilmore J. Smart wound dressings for diabetic chronic wounds. Bioengineering. 2018;5(3):51.","journal-title":"Bioengineering"},{"issue":"265","key":"220_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/scitranslmed.3009337","volume":"6","author":"SA Eming","year":"2014","unstructured":"Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014;6(265):265.","journal-title":"Sci Transl Med"},{"issue":"2","key":"220_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2337\/diacare.24.2.290","volume":"24","author":"A Veves","year":"2001","unstructured":"Veves A, Falanga V, Armstrong DG, Sabolinski M. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24(2):290\u20135.","journal-title":"Diabetes Care"},{"issue":"5","key":"220_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1524-475X.2000.00347.x","volume":"8","author":"V Falanga","year":"2000","unstructured":"Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 2000;8(5):347\u201352.","journal-title":"Wound Repair Regen"},{"issue":"2","key":"220_CR8","first-page":"76","volume":"2","author":"M Mulder","year":"2009","unstructured":"Mulder M. The selection of wound care products for wound bed preparation. Wound Healing South Afr. 2009;2(2):76\u20138.","journal-title":"Wound Healing South Afr"},{"issue":"2","key":"220_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajps.2018.04.004","volume":"14","author":"L Yan","year":"2019","unstructured":"Yan L, Shiya Z, Yanlin G, Yinglei Z. Electrospun nanofibers as a wound dressing for treating diabetic foot ulcer. Asian J Pharm Sci. 2019;14(2):130\u201343.","journal-title":"Asian J Pharm Sci"},{"issue":"suppl1","key":"220_CR10","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1111\/j.1526-4637.2004.04020.x","volume":"5","author":"MM Backonja","year":"2004","unstructured":"Backonja MM, Serra J. Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Med. 2004;5(suppl1):S28\u201347.","journal-title":"Pain Med"},{"issue":"5","key":"220_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1592\/phco.24.6.621.34748","volume":"24","author":"DR Grothe","year":"2004","unstructured":"Grothe DR, Scheckner B, Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy. 2004;24(5):621\u20139.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"220_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jdiacomp.2007.03.010","volume":"22","author":"AK Kadiroglu","year":"2008","unstructured":"Kadiroglu AK, Sit D, Kayabasi H, Tuzcu AK, Tasdemir N, Yilmaz ME. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complicat. 2008;22(4):241\u20135.","journal-title":"J Diabetes Complicat"},{"issue":"2","key":"220_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/infdis\/170.2.377","volume":"170","author":"P Richard","year":"1994","unstructured":"Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Richet H. Pseudomonas aeruginosa outbreak in a burn unitrole of antimicrobials in the emergence of multiply resistant strains. J Infect Dis. 1994;170(2):377\u201383.","journal-title":"J Infect Dis"},{"issue":"8","key":"220_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/art.1780370802","volume":"37","author":"MP Vincenti","year":"1994","unstructured":"Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier saidthan done? Arthritis Rheum. 1994;37(8):1115\u201326.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"220_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1211\/jpp.61.12.0005","volume":"61","author":"N Adhirajan","year":"2009","unstructured":"Adhirajan N, Shanmugasundaram N, Shanmuganathan S, Babu M. Collagen-based wound dressing for doxycycline delivery: in-vivo evaluation in an infected excisional wound model in rats. J Pharm Pharmacol. 2009;61(12):1617\u201323.","journal-title":"J Pharm Pharmacol"},{"key":"220_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.msec.2016.08.086","volume":"70","author":"H Chen","year":"2017","unstructured":"Chen H, Xing X, Tan H, Jia Y, Zhou T, Chen Y, et al. Covalently antibacterial alginate-chitosan hydrogel dressing integrated gelatin microspheres containing tetracycline hydrochloride for wound healing. Mater Sci Eng C. 2017;70:287\u201395.","journal-title":"Mater Sci Eng C"},{"issue":"23","key":"220_CR17","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1039\/c3tb20149j","volume":"1","author":"L Huang","year":"2013","unstructured":"Huang L, Chen X, Nguyen TX, Tang H, Zhang L, Yang G. Nano-cellulose 3D-networks as controlled-release drug carriers. J Mater Chem B. 2013;1(23):2976\u201384.","journal-title":"J Mater Chem B"},{"key":"220_CR18","doi-asserted-by":"publisher","first-page":"66886","DOI":"10.1039\/C5RA10880B","volume":"5","author":"HFO Silva","year":"2015","unstructured":"Silva HFO, Lima KMG, Cardoso MB, Oliveira JFA, Melo MCN, Sant\u2019Anna C, et al. Doxycycline conjugated with polyvinylpyrrolidone-encapsulated silver nanoparticles: a polymer\u2019s malevolent touch against Escherichia coli. RSC Adv. 2015;5:66886\u201393.","journal-title":"RSC Adv"},{"issue":"7","key":"220_CR19","first-page":"1246","volume":"2","author":"NA Karani","year":"2009","unstructured":"Karani NA, Pingale P. Analytical method development & validation of venlafaxine hydrochloride in solid dosage forms using uv spectrophotometer. J Pharm Res. 2009;2(7):1246\u20139.","journal-title":"J Pharm Res"},{"issue":"2","key":"220_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1208\/s12249-010-9457-1","volume":"11","author":"C Salerno","year":"2010","unstructured":"Salerno C, Carlucci AM, Bregni C. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS Pharmscitech. 2010;11(2):986\u201393.","journal-title":"AAPS Pharmscitech"},{"key":"220_CR21","doi-asserted-by":"publisher","first-page":"e3266","DOI":"10.1002\/dmrr.3266","volume":"36","author":"NC Schaper","year":"2020","unstructured":"Schaper NC, et al. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3266.","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"220_CR22","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","volume":"17","author":"EL Feldman","year":"1994","unstructured":"Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17(11):1281\u20139.","journal-title":"Diabetes Care"},{"issue":"7","key":"220_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","volume":"29","author":"WH Herman","year":"2012","unstructured":"Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications. Diabet Med. 2012;29(7):937\u201344.","journal-title":"Diabet Med"},{"issue":"5","key":"220_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","volume":"108","author":"A Moghtaderi","year":"2006","unstructured":"Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108(5):477\u201381.","journal-title":"Clin Neurol Neurosurg"},{"key":"220_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.carbpol.2014.02.014","volume":"106","author":"NHCS Silva","year":"2014","unstructured":"Silva NHCS, Rodrigues AF, Almeida IF, Costa PC, Rosado C, Neto CP, et al. Bacterial cellulose membranes as transdermal delivery systems for diclofenac: in vitro dissolution and permeation studies. Carbohyd Polym. 2014;106:264\u20139.","journal-title":"Carbohyd Polym"},{"issue":"7","key":"220_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1517\/17425247.2014.920819","volume":"11","author":"AJ Silvestre","year":"2014","unstructured":"Silvestre AJ, Freire CS, Neto CP. Do bacterial cellulose membranes have potential in drug-delivery systems? Expert Opin Drug Deliv. 2014;11(7):1113\u201324.","journal-title":"Expert Opin Drug Deliv"},{"issue":"11","key":"220_CR27","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1021\/bm201303r","volume":"12","author":"E Trovatti","year":"2011","unstructured":"Trovatti E, Silva NHCS, Duarte IF, Rosado CF, Almeida IF, Costa P, et al. Biocellulose membranes as supports for dermal release of lidocaine. Biomacromol. 2011;12(11):4162\u20138.","journal-title":"Biomacromol"},{"issue":"2","key":"220_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2005.07.035","volume":"27","author":"W Czaja","year":"2006","unstructured":"Czaja W, Krystynowicz A, Bielecki S, Brown RM Jr. Microbial cellulose\u2014the natural power to heal wounds. Biomaterials. 2006;27(2):145\u201351.","journal-title":"Biomaterials"},{"issue":"3","key":"220_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2008.05.001","volume":"129","author":"R Suedee","year":"2008","unstructured":"Suedee R, Bodhibukkana C, Tangthong N, Amnuaikit C, Kaewnopparat S, Srichana T. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemicpropranolol using a molecularly imprinted polymer composite membrane. J Control Rel. 2008;129(3):170\u20138.","journal-title":"J Control Rel"},{"issue":"5","key":"220_CR30","first-page":"561","volume":"41","author":"MCIM Amin","year":"2012","unstructured":"Amin MCIM, Abadi AG, Ahmad N, Katas H, Jamal JA. Bacterial cellulose film coating as drug delivery system: physicochemical, thermal and drug release properties. Sains Malaysiana. 2012;41(5):561\u20138.","journal-title":"Sains Malaysiana"},{"issue":"3","key":"220_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s10924-011-0323-3","volume":"19","author":"Z Man","year":"2011","unstructured":"Man Z, Muhammad N, Sarwono A, Bustam MA, Kumar MV, Rafiq S. Preparation of cellulose nanocrystals using an ionic liquid. J Polym Environ. 2011;19(3):726\u201331.","journal-title":"J Polym Environ"},{"issue":"12\u201313","key":"220_CR32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.fuel.2006.12.013","volume":"86","author":"H Yang","year":"2007","unstructured":"Yang H, Yan R, Chen H, Lee DH, Zheng C. Characteristics of hemicellulose, cellulose and lignin pyrolysis. Fuel. 2007;86(12\u201313):1781\u20138.","journal-title":"Fuel"},{"issue":"1","key":"220_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10570-013-0114-1","volume":"21","author":"NHCS Silva","year":"2014","unstructured":"Silva NHCS, Drumond I, Almeida IF, Costa P, Rosado CF, Neto CP, et al. Topical caffeine delivery using biocellulose membranes: a potential innovative system for cellulite treatment. Cellulose. 2014;21(1):665\u201374.","journal-title":"Cellulose"},{"key":"220_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jddst.2016.03.008","volume":"33","author":"BM Shah","year":"2016","unstructured":"Shah BM, Khunt D, Bhatt HS, Misra M, Padh H. Intranasal delivery of venlafaxine loaded nanostructured lipid carrier: risk assessment and QbD based optimization. J Drug Deliv Sci Technol. 2016;33:37\u201350.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"220_CR35","first-page":"183","volume":"8","author":"N Kumar","year":"2016","unstructured":"Kumar N, Das S, Jyoti A, Kaushik S. Synergistic effect of silver nanoparticles with doxycycline against Klebsiella pneumoniae. Int J Pharm Pharm Sci. 2016;8(7):183\u20136.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"1\u20132","key":"220_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.clay.2010.11.013","volume":"51","author":"HA Patel","year":"2011","unstructured":"Patel HA, Shah S, Shah DO, Joshi PA. Sustained release of venlafaxine from venlafaxine\u2013montmorillonite\u2013polyvinylpyrrolidone composites. Appl Clay Sci. 2011;51(1\u20132):126\u201330.","journal-title":"Appl Clay Sci"},{"key":"220_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.msec.2017.03.095","volume":"76","author":"MS Marques","year":"2017","unstructured":"Marques MS, Zepon KM, Petronilho FC, Soldi V, Kanis LA. Characterization of membranes based on cellulose acetate butyrate\/poly (caprolactone) triol\/doxycycline and their potential for guided bone regeneration application. Mater Sci Eng C. 2017;76:365\u201373.","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"220_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijpharm.2012.01.002","volume":"435","author":"E Trovatti","year":"2012","unstructured":"Trovatti E, Freire CSR, Pinto PC, Almeida IF, Costa P, Silvestre AJD, et al. Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies. Int J Pharm. 2012;435(1):83\u20137.","journal-title":"Int J Pharm"},{"issue":"1","key":"220_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.carbpol.2010.12.017","volume":"84","author":"B Wei","year":"2011","unstructured":"Wei B, Yang G, Hong F. Preparation and evaluation of a kind of bacterial cellulose dry films with antibacterial properties. Carbohyd Polym. 2011;84(1):533\u20138.","journal-title":"Carbohyd Polym"},{"issue":"2","key":"220_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jps.23385","volume":"102","author":"A M\u00fcller","year":"2013","unstructured":"M\u00fcller A, Ni Z, Hessler N, Wesarg F, M\u00fcller FA, Kralisch D, et al. The biopolymer bacterial nanocellulose as drug deliverysystem: investigation of drug loading and release using the model protein albumin. J Pharm Sci. 2013;102(2):579\u201392.","journal-title":"J Pharm Sci"},{"issue":"87","key":"220_CR41","doi-asserted-by":"publisher","first-page":"47056","DOI":"10.1039\/C4RA09640A","volume":"4","author":"X Shi","year":"2014","unstructured":"Shi X, Zheng Y, Wang G, Lin Q, Fan J. pH-and electro-response characteristics of bacterial cellulose nanofiber\/sodium alginatehybrid hydrogels for dual controlled drug delivery. RSC Adv. 2014;4(87):47056\u201365.","journal-title":"RSC Adv"},{"issue":"1","key":"220_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejps.2013.02.023","volume":"50","author":"H Valo","year":"2013","unstructured":"Valo H, Arola S, Laaksonen P, Torkkeli M, Peltonen L, Linder MB, et al. Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels. Eur J Pharm Sci. 2013;50(1):69\u201377.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"220_CR43","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2478\/s11532-014-0541-3","volume":"12","author":"RD Pavaloiu","year":"2014","unstructured":"Pavaloiu RD, Stoica A, Stroescu M, Dobre T. Controlled release of amoxicillin from bacterial cellulose membranes. Open Chem. 2014;12(9):962\u20137.","journal-title":"Open Chem"},{"issue":"3","key":"220_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pharmaceutics10030148","volume":"10","author":"CH Salamanca","year":"2018","unstructured":"Salamanca CH, Barrera-Ocampo A, Lasso JC, Camacho N, Yarce CJ. Franz diffusion cell approach for pre formulation characterization of ketoprofen semi-solid dosage forms. Pharmaceutics. 2018;10(3):148.","journal-title":"Pharmaceutics"},{"issue":"3","key":"220_CR45","first-page":"192","volume":"19","author":"N Razazian","year":"2014","unstructured":"Razazian N, Baziyar M, Moradian N, Afshari D, Bostani A, Mahmoodi M. Evaluation of the efficacy and safety of pregabalin, venlafaxineand carbamazepine in patients with painful diabetic peripheral neuropathy: a randomized, double-blind trial. Neurosciences. 2014;19(3):192\u20138.","journal-title":"Neurosciences"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00220-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-021-00220-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00220-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T23:18:07Z","timestamp":1666999087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-021-00220-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00220-8","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Isfahan University of Medical Sciences ethics committee (license code of 9531) and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}